Literature DB >> 16733879

Comparative reflections on the Belgian Euthanasia Act 2002.

Maurice Adams1, Herman Nys.   

Abstract

Keywords:  Death and Euthanasia; Legal Approach

Mesh：

Year:  2003        PMID： 16733879     DOI： 10.1093/medlaw/11.3.353

Source DB:  PubMed          Journal:  Med Law Rev        ISSN： 0967-0742            Impact factor:   1.267


× No keyword cloud information.
  6 in total

1.  Making sense of continuous sedation in end-of-life care for cancer patients: an interview study with bereaved relatives in three European countries.

Authors:  S M Bruinsma; J Brown; A van der Heide; L Deliens; L Anquinet; S A Payne; J E Seymour; J A C Rietjens
Journal:  Support Care Cancer       Date:  2014-07-15       Impact factor: 3.603

2.  RE: "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

Authors:  Andrea Martani; Marta Tomasi; Carlo Casonato
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

3.  Relationship Between COVID-19, Euthanasia and Old Age: A Study from a Legal-Ethical Perspective.

Authors:  Jorge Salinas Mengual
Journal:  J Relig Health       Date:  2021-05-20

4.  Two Decades of Research on Euthanasia from the Netherlands. What Have We Learnt and What Questions Remain?

Authors:  Judith A C Rietjens; Paul J van der Maas; Bregje D Onwuteaka-Philipsen; Johannes J M van Delden; Agnes van der Heide
Journal:  J Bioeth Inq       Date:  2009-07-28       Impact factor: 1.352

5.  Reporting of euthanasia and physician-assisted suicide in the Netherlands: descriptive study.

Authors:  Hilde Buiting; Johannes van Delden; Bregje Onwuteaka-Philpsen; Judith Rietjens; Mette Rurup; Donald van Tol; Joseph Gevers; Paul van der Maas; Agnes van der Heide
Journal:  BMC Med Ethics       Date:  2009-10-27       Impact factor: 2.652

6.  Palliative care professionals' willingness to perform euthanasia or physician assisted suicide.

Authors:  Julia Zenz; Michael Tryba; Michael Zenz
Journal:  BMC Palliat Care       Date:  2015-11-14       Impact factor: 3.234
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.